This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pollack A et al. (2000) Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy to 78 Gy for prostate cancer. J Clin Oncol 18: 3904–3011
Zietman AL et al. (2005) Comparison of conventional-dose vs high dose conformal therapy in clinically localized adenocarcinoma of the prostate. JAMA 294: 1233–1239
Peeters STH et al. (2006) Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24: 1990–1996
Dearnaley DP et al. (2007) Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomized controlled trial. Lancet Oncol 8: 475–487
D'Amico A et al. (2008) Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA 299: 289–295
Acknowledgements
The synopsis was written by Nick Groves-Kirkby, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Bolla, M. What is the role of radiation dose escalation in the treatment of localized prostate cancer?. Nat Rev Urol 5, 418–419 (2008). https://doi.org/10.1038/ncpuro1153
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro1153